M Jauffret-Roustide
Datos Biográficos
| ID | 7448386 |
|---|---|
| NOMBRE | M Jauffret-Roustide |
| NOMBRES | M |
| APELLIDO | Jauffret-Roustide |
| FIRMA | JAUFFRET-ROUSTIDE M |
| VERIFICADO | No |
| TOTAL DE OBRAS | 5 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 5 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2017 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2024 |
| ÍNDICE H | 0 |
How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023
BACKGROUND: With the advent of direct acting antivirals (DAAs) the World Health Organisation (WHO) adopted global strategy to eliminate hepatitis C virus (HCV) infection by 2030. In Europe, people who inject drugs (PWID) account for the majority of new cases, however testing and treatment remain suboptimal. The aim was to monitor progress in HCV policy and cascade-of-care for PWID, led by the civil society organisations (CSO) that provide harm re…
The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries
BACKGROUND: People who inject drugs (PWID) account for the majority of new cases of hepatitis C virus (HCV) infection in Europe; however, HCV testing, and treatment for PWID remain suboptimal. With the advent of direct acting antivirals (DAAs) the World Health Organization (WHO) adopted a strategy to eliminate HCV as public health threat by 2030. To achieve this, key policies for PWID must be implemented and HCV continuum of care needs to be moni…
Do DSM-5 substance use disorder criteria differ by user care settings? An item response theory analysis approach
Migration experiences, life conditions, and drug use practices of Russian-speaking drug users who live in Paris
BACKGROUND: After the collapse of the Soviet Union at the beginning of the 1990s, people who inject drugs spiked in Eastern Europe. Facing local repression and an array of factors encouraging emigration, some users have migrated to France. This population now make up to a third of the patient list of some harm reduction services in Paris. This article aims to present original data on the sociodemographic profiles of these users, on their migratio…
Restrictions on access to direct-acting antivirals for people who inject drugs
Sin obras prominentes en esta página.
Restrictions on access to direct-acting antivirals for people who inject drugs
The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries
BACKGROUND: People who inject drugs (PWID) account for the majority of new cases of hepatitis C virus (HCV) infection in Europe; however, HCV testing, and treatment for PWID remain suboptimal. With the advent of direct acting antivirals (DAAs) the World Health Organization (WHO) adopted a strategy to eliminate HCV as public health threat by 2030. To achieve this, key policies for PWID must be implemented and HCV continuum of care needs to be moni…
Do DSM-5 substance use disorder criteria differ by user care settings? An item response theory analysis approach
Migration experiences, life conditions, and drug use practices of Russian-speaking drug users who live in Paris
BACKGROUND: After the collapse of the Soviet Union at the beginning of the 1990s, people who inject drugs spiked in Eastern Europe. Facing local repression and an array of factors encouraging emigration, some users have migrated to France. This population now make up to a third of the patient list of some harm reduction services in Paris. This article aims to present original data on the sociodemographic profiles of these users, on their migratio…
How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023
BACKGROUND: With the advent of direct acting antivirals (DAAs) the World Health Organisation (WHO) adopted global strategy to eliminate hepatitis C virus (HCV) infection by 2030. In Europe, people who inject drugs (PWID) account for the majority of new cases, however testing and treatment remain suboptimal. The aim was to monitor progress in HCV policy and cascade-of-care for PWID, led by the civil society organisations (CSO) that provide harm re…
Medicine (5 obras) · Hepatitis C virus research (4 obras) · HIV, Drug Use, Sexual Risk (4 obras) · Psychology (4 obras) · Harm reduction (3 obras) · Health care (3 obras) · Hepatitis B Virus Studies (3 obras) · Nursing (3 obras) · Psychiatry (3 obras) · Public health (3 obras)